- Home
- Standardized Extracts
- Ginkgo Extract
Ginkgo Extract (Ginkgo biloba) – Bilobalide 2.6–3.2%
Ginkgo biloba
- Marker compound
- Bilobalide
- Standardisation
- 2.6–3.2% (HPLC)
- Assay method
- HPLC
- CAS
- 33570-04-6
- Plant part
- Leaf
- Origin
- China, France, United States
Ginkgo Extract (Ginkgo biloba) – Bilobalide 2.6–3.2%
Ginkgo extract is produced from the leaf of Ginkgo biloba (Ginkgoaceae family) and supplied as a standardized extract powder, standardized to Bilobalide. Available grades: 2.6%, 3.2%. Typical sourcing: China, France, United States. For B2B formulation in nutraceuticals & supplements.
2.6%3.2%
Specifications
| Botanical name | Ginkgo biloba |
| Common names | Ginkgo |
| Plant family / part | Ginkgoaceae / Leaf |
| Marker compound | Bilobalide |
| Phytochemical class | Terpenoids › Diterpenes & diterpene glycosides |
| Available grades | 2.6%, 3.2% |
| Assay method | HPLC |
| CAS number | 33570-04-6 |
| Pharmacopoeia & standards | USP, Ph. Eur. (EP), British Pharmacopoeia, Chinese Pharmacopoeia, EMA herbal monograph, ESCOP monograph, WHO monograph |
| Form | Standardized Extract |
| Origin | China, France, United States |
| Pack sizes | Sample (50 g), 250 g, 1 Kg, 5 Kg, 25 Kg |
| Shelf life & storage | Typically 24 months in sealed original packaging; store cool, dry and away from light |
Formulation focus
- Cognitive Health
- Heart & Circulation
Industries
Nutraceuticals & Supplements
Traditional systems: Traditional Chinese Medicine, European herbal tradition
Documentation
Batch Certificate of Analysis, Technical Data Sheet and MSDS available on request. Confirm the assay method (HPLC, UV or gravimetric) on the CoA, as results differ between methods.
For B2B formulation and research use. Statements have not been evaluated by the FDA or other regulators; this ingredient is not intended to diagnose, treat, cure or prevent any disease.
Same product form